Barclays’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-5
| Closed | – | – | 4658 |
|
|
2018
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 4623 |
|
|
2017
Q4 | – | Sell |
-100
| Closed | – | – | 4382 |
|
|
2017
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 4335 |
|
|
2017
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 4352 |
|
|
2017
Q1 | $0 | Sell |
100
-3,684
| -97% | – | ﹤0.01% | 4340 |
|
|
2016
Q4 | $6K | Buy |
3,784
+3,527
| +1,372% | +$5.59K | ﹤0.01% | 3422 |
|
|
2016
Q3 | $0 | Sell |
257
-2,476
| -91% | – | ﹤0.01% | 4278 |
|
|
2016
Q2 | $12K | Buy |
2,733
+1,304
| +91% | +$5.73K | ﹤0.01% | 2954 |
|
|
2016
Q1 | $0 | Sell |
1,429
-611
| -30% | – | ﹤0.01% | 4009 |
|
|
2015
Q4 | $20K | Sell |
2,040
-11,918
| -85% | -$117K | ﹤0.01% | 2705 |
|
|
2015
Q3 | $279K | Buy |
13,958
+11,447
| +456% | +$229K | ﹤0.01% | 1985 |
|
|
2015
Q2 | $100K | Buy |
2,511
+1,138
| +83% | +$45.3K | ﹤0.01% | 2362 |
|
|
2015
Q1 | $97K | Sell |
1,373
-118
| -8% | -$8.34K | ﹤0.01% | 2523 |
|
|
2014
Q4 | $89K | Sell |
1,491
-8,316
| -85% | -$496K | ﹤0.01% | 2762 |
|
|
2014
Q3 | $393K | Sell |
9,807
-8,023
| -45% | -$322K | ﹤0.01% | 2055 |
|
|
2014
Q2 | $1.07M | Buy |
17,830
+13,202
| +285% | +$792K | ﹤0.01% | 1670 |
|
|
2014
Q1 | $278K | Sell |
4,628
-5,960
| -56% | -$358K | ﹤0.01% | 2231 |
|
|
2013
Q4 | $529K | Buy |
10,588
+3,789
| +56% | +$189K | ﹤0.01% | 2119 |
|
|
2013
Q3 | $408K | Buy |
6,799
+3,264
| +92% | +$196K | ﹤0.01% | 2234 |
|
|
2013
Q2 | $206K | Buy |
+3,535
| New | +$206K | ﹤0.01% | 2674 |
|